Background BRCA1 and, more commonly, BRCA2 mutations are associated with increased
risk of male breast cancer (MBC). However, only a paucity of data exists on the pathology of …

Male breast cancer is rare, and experience of it in any single institution is limited. Our current
understanding regarding its biology, natural history, and treatment strategies has been …

Abstract Learning Objectives After completing this course, the reader will be able to: List the
risk factors for male breast cancer. Explain the differences between breast cancer in men …

Background Male breast cancer is rare and understudied compared with female breast
cancer. A current comparison with female breast cancer could assist in bridging this gap …

Male breast cancer is rare. Median age at diagnosis is~ 65 years, and> 35% of male breast
cancers occur in elderly men. Retroareolar lump is the most frequent symptom, and 25–30 …

Male breast cancer (MBC) is rare. We assembled 446 MBCs on tissue microarrays and
assessed clinicopathological information, together with data from 15 published studies …

Purpose Male breast cancer is a rare disease with an incidence rate less than 1% of that of
female breast cancer. Given its low incidence, few studies have assessed risk and …

Carcinoma of the male breast (MBC) is an uncommon phenomenon, accounting for< 1% of
all malignancies in man. It represents a biologically heterogeneous disorder, and its clinical …

Male breast cancer (MBC) is on the rise in the United States [Surveillance, Epidemiology,
and End Results (SEER) Program () SEER Stat Database: Incidence-SEER 9 Regs Public …

PURPOSE To develop recommendations concerning the management of male breast
cancer. METHODS ASCO convened an Expert Panel to develop recommendations based …